-+ 0.00%
-+ 0.00%
-+ 0.00%
Houlihan Lokey (HLI) Stock May Be Trading At A Discount Following Its 44% Three Year Gain
Share
Listen to the news

Houlihan Lokey has delivered a 43.9% gain over the past three years, even though the stock is down sharply over the past year. That puts fresh attention on whether the share price is still aligned with the returns the business earns on its capital. Recent deal activity and acquisitions add another layer to that question because they can reshape how efficiently the firm puts new capital to work.

  • The 43.9% three year return raises the issue of whether the market is already baking in all the value of the returns Houlihan Lokey generates on the capital it deploys.
  • The planned acquisition of Vicente & Partners expands Houlihan Lokey's presence in beauty, personal care and pet health advisory, which can influence future fee mix, required investment and the sustainability of its capital returns over time.
  • If you'd rather focus on earnings, this one's for you. See why Houlihan Lokey's 24.6x P/E tells a different valuation story.

The stock's next move may depend on whether the returns Houlihan Lokey earns on its capital are strong enough to justify where the shares trade today.

If you want to test the same question about returns on capital across a wider set of companies, take a look at 32 high quality undervalued stocks.

Is Houlihan Lokey Still Cheap on Excess Returns?

The Excess Returns model looks at how much profit Houlihan Lokey earns above its required cost of equity. On the inputs used here, the firm is expected to generate stable earnings of $8.68 per share on a stable book value base of $39.46 per share, with analysts implying an average return on equity of 22.01%. Against a cost of equity of $3.12 per share, that leaves an excess return of $5.56 per share. This excess return is what drives most of the estimated intrinsic value rather than aggressive growth in the balance sheet.

Book value today is $33.24 per share, so the model relies on that projected build in equity and sustained profitability to arrive at an intrinsic value meaningfully above the current share price of $142.84. Because the Vicente & Partners deal targets higher fee beauty, personal care and pet health advisory work, the acquisition helps explain why the market is willing to pay a premium multiple, while the Excess Returns framework still indicates the shares offer more value on the underlying economics. Find out what Houlihan Lokey could be worth using our Excess Returns estimate.

The Houlihan Lokey Narrative: What Would Justify Today's Price?

Houlihan Lokey's Narratives on Simply Wall St pick up directly from this valuation puzzle by spelling out which assumptions on growth, margins and earnings would need to hold for the shares to be worth materially more or less than today’s price. Each scenario lays out its own fair value logic so you can compare those assumptions with the actual results as they are reported on the Community page.

One of the top narratives on Houlihan Lokey: 11% undervalued

This Narrative is the analyst consensus Narrative on Simply Wall St, which compiles analysts' consensus price target and revenue and earnings forecasts, not one person's view.

"The main thing that has to go right is that Houlihan Lokey converts its record Corporate Finance pipelines and growing Capital Solutions and secondaries activity into completed higher fee transactions..."

Discover why this Narrative puts Houlihan Lokey at 11% undervalued.

For Houlihan Lokey, the share price story is only half the decision

Who steers Houlihan Lokey, how they are rewarded, and whether those incentives line up with shareholder outcomes can be just as important as any model output. See who runs Houlihan Lokey and how they are paid.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending